Dividends CalendarEarnings Calendar

ZYNE | Zynerba Phamaceuticals Inc

4.18 -0.15 (-3.62%) 
Zynerba Phamaceuticals Inc

Company profile

  • Industry: Biotechnology
  • Sector: Healthcare
  • Headquarters:   Devon, Pennsylvania, United States
  • Number of employees::   28

Company profile

Zynerba (NASDAQ: ZYNE) is dedicated to improving the lives of people with rare and near rare neuropsychiatric disorders where there is a high unmet medical need by pioneering the development and commercialization of next-generation pharmaceutically-produced cannabinoid therapeutics formulated for transdermal delivery.


    80 W. Lancaster Avenue, Suite 300
    Devon, PA 19333

      Key Persons / Board of Directors

      • CEO :  Armando Anido
      • General Counsel :  Suzanne M. Hanlon
      • Chief Medical Officer :  Joseph M. Palumbo (Md, Fapa, Macpsych)

      Jump to (Finance sites)


      If you are looking for News & events, Press Release, they are available on their Investors Relationssite.

      BUY 83
      HOLD 17
      SELL 0

      Their Official Profiles 


      Peers / Similar stocks 


      Other stocks 

      s kmx lrcx bks etr sptn schw agn vips xray veev roku 

      Support this project

      If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
      More features coming soon :)

      Social Media 

      Recommended Books

      Investing For Dummies
      Buy on Amazon

      In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.